CCIA
MRTX

Campbell & Co Investment Adviser’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31,587
Closed -$1.38M – 1410
2023
Q3 		$1.38M Buy
+31,587
New +$1.38M 0.16% 174
2022
Q3 		– Sell
-6,557
Closed -$440K – 989
2022
Q2 		$440K Buy
6,557
+2,634
+67% +$177K 0.12% 318
2022
Q1 		$323K Buy
+3,923
New +$323K 0.09% 450